Daniel J Przybylski

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Prognostic Factors

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

This page only lists publications with an associated author ORCID identifier.

Publications

Keng Hee Peh, Daniel J Przybylski, Michael J Fallon, Jason J Bergsbaken, Paul R Hutson, Menggang Yu, Dustin A Deming, Mark E Burkard
Clinical utility of a regional precision medicine molecular tumor board and challenges to implementation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Daniel J Przybylski, Jason R Jared, Michael J Fallon
Extemporaneous compounding and administration of tretinoin slurry for acute promyelocytic leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (7) (2021)
Daniel J Przybylski, Jason J Bergsbaken, Jennifer K Piccolo
Unleashing the power of immunotherapy and targeted therapy combinations: Advancing cancer care or discovering unknown toxicities? Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 27 (4) (2021)
Daniel J Przybylski, Elizabeth N Dow-Hillgartner, Michael P Reed, Michael J Fallon
Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (6) (2020)